Clinical and economic analysis of the use of apixaban for the treatment of venous thromboembolic events
Aim. Pharmacoeconomic analysis of apixaban use compared to conventional therapy in patients with venous thromboembolism (VTE).Material and methods. Economic evaluation was performed from a position of the health care system. The cost analysis, "cost-effectiveness" analysis, "impact on...
Saved in:
| Main Author: | O. V. Shatalova |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Столичная издательская компания
2015-12-01
|
| Series: | Рациональная фармакотерапия в кардиологии |
| Subjects: | |
| Online Access: | https://www.rpcardio.online/jour/article/view/439 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Efficacy and safety of the new oral anticoagulants in the treatment of venous thromboembolic complications: meta-analysis
by: V. I. Petrov, et al.
Published: (2017-01-01) -
Efficacy and safety of the new oral anticoagulants in the treatment of venous thromboembolic complications: meta-analysis
by: V. I. Petrov, et al.
Published: (2016-03-01) -
Hospitalizations for bleeding associated with apixaban versus rivaroxaban according to dose in Medicare beneficiaries
by: Luke S. Vest, et al.
Published: (2025-09-01) -
THE ADVANCED TACTICS OF THE MANAGEMENT OF PATIENTS WITH VENOUS THROMBOEMBOLISM: THE ROLE OF RIVAROXABAN AT VARIOUS STAGES OF TREATMENT
by: S. R. Gilyarevskiy
Published: (2016-06-01) -
The Current Status of Direct Oral Anticoagulants in Cancer-Related Venous Thromboembolism Treatment
by: К. V. Lobastov, et al.
Published: (2020-05-01)